头对头对比：智能生物解决方案（INBS）与竞赛

Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) is one of 223 public companies in the "Surgical & medical instruments" industry, but how does it compare to its rivals? We will compare Intelligent Bio Solutions to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, institutional ownership, profitability and earnings.

Institutional and Insider Ownership

2.3% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 45.8% of shares of all "Surgical & medical instruments" companies are held by institutional investors. 1.9% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 15.2% of shares of all "Surgical & medical instruments" companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Get Intelligent Bio Solutions alerts:

Analyst Ratings

This is a breakdown of current recommendations and price targets for Intelligent Bio Solutions and its rivals, as provided by MarketBeat.

As a group, "Surgical & medical instruments" companies have a potential upside of 21.50%. Given Intelligent Bio Solutions' rivals higher possible upside, analysts clearly believe Intelligent Bio Solutions has less favorable growth aspects than its rivals.

Profitability

This table compares Intelligent Bio Solutions and its rivals' net margins, return on equity and return on assets.

Volatility & Risk

Intelligent Bio Solutions has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions' rivals have a beta of 1.37, indicating that their average stock price is 37% more volatile than the S&P 500.

Valuation & Earnings

This table compares Intelligent Bio Solutions and its rivals top-line revenue, earnings per share (EPS) and valuation.

Intelligent Bio Solutions' rivals have higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Intelligent Bio Solutions rivals beat Intelligent Bio Solutions on 7 of the 10 factors compared.

Intelligent Bio Solutions Company Profile

(Get Rating)

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.